Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Mansoura Medical Journal. 2006; 37 (3,4): 133-160
Dans Anglais | IMEMR | ID: emr-150947

Résumé

Opioid analgesics are used widely to control various types of pain. Several studies reported that opioid analgesics may produce lowering plasma glucose. The present work aims to investigate the effect of both tramadol and fentanyl on the plasma glucose and liver glycogen of streptozotocin [STZ] induced diabetic rats and declares the possible mechanism of this effect. IV administration of either tramadol or fentanyl for 4 successive days in STZ-induced diabetic rats produced significant reduction in fasting and random plasma glucose in comparison with non-treated STZ-induced diabetic rats. IV Naloxone [mu opioid [MOP] receptor blocker] 30 min. before administration of either tramadol or fentanyl blocked the effect of both tramadol and fentanyl on fasting and random plasma glucose. IV injection of both tramadol and fentanyl in STZ-induced diabetic rats for 4 successive days, produced significant recovery [increase] of glycogen content of the liver in diabetic rats compared with diabetic non-treated group. This effect was also blocked by IV naloxone administration 30 min before administration of either tramadol or fentanyl. The histochemical examination of PAS stained sections of the liver, prepared from rats used during this work, confirmed the results obtained by chemical detection of glycogen content of the liver homogenate. I.V injection of either tramadol or fentanyl produced significant increase in pain tolerance. I.V naloxone 30 min. before adminstration of either tramadol or fentanyl partially blocked the analgesic effect of tramadol, while the analgesic effect of fentanyl was completely blocked. These results suggested that both tramadol and fentanyl have a significant anti-hyperglycemic effect. This effect could be through activation of MOP receptors which may be mediated through increased glycogen deposition in the liver


Sujets)
Mâle , Animaux de laboratoire , Glycémie , Glycogène hépatique/sang , Diabète expérimental , Tramadol/toxicité , Fentanyl , Naloxone , Rats
2.
Mansoura Medical Journal. 1997; 27 (3-4): 281-305
Dans Anglais | IMEMR | ID: emr-108303

Résumé

This study was conducted to investigate the effects of chronic oral melatonin administration in dose of 0.4 mg/kg B.W. daily for 30 days on serum TSH, T4, FSH, LH and insulin. 160 albino rats of both sexes were used, they were grouped into 16 groups, of which 8 groups were used to investigate the endocrinal effects of melatonin in both light and dark conditions. The other 8 groups were used for the same investigations under stressful condition in both light and dark as well. Half of all these groups were served as placebo controls. It was concluded that exogenous melatonin is recommended only as replacement therapy for persons sleeping in light to avoid disturbance of thyroid function especially in hyperthyroid patients. Also, melatonin has no role in counteracting the effects of acute stress on the endocrine functions related to TSH, T4, LH, FSH and insulin


Sujets)
Hormone folliculostimulante , Thyréostimuline , Hormone lutéinisante , Rats
SÉLECTION CITATIONS
Détails de la recherche